Novastep Deal Consumated
As speculated in February 2023 FIX, Enovis announced early this week that it has consummated a deal for Novastep with the MIS bunion system being the prize along with access to a robust OUS sales channel.
Where does this leave Carbon-22?
No word yet on how this affects the strategic relationship between Novastep and Carbon22. In 2020, Novastep announced an exclusive distribution and education agreement with Carbon22. Carbon22, a GLW company, is a musculoskeletal company, comprised of a consortium of orthopedic and podiatric surgeons focusing on foot and ankle implant solutions. The sales price is around $74.4 million based on current rates.
Recent Posts
See AllBioAventis has agreed to sell its wound business to LifeNet Health, which includes skin substitutes TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. Indu
Dr. Ned Amendola MD, FAAOS, FRCS(C) from Duke University was named second vice president of the American Academy of Orthopedic Surgeons (AAOS) and will ascend to president in 2025-2026. Fellowship tra
Startup capital is the fuel for innovation in foot and ankle surgery. There are several sources for capital with debt financing through banks representing one of them. Competition is good and the more
